© Globe Newswire
10.12.2025
WVE
LISTED
NASDAQ
Wave Life Sciences Prices Upsized $350 Million Public Offering of Ordinary Shares and Pre-Funded Warrants
News Preview
CAMBRIDGE, Mass., Dec. 09, 2025 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health (“Wave” or “Wave Life Sciences”), announced today the pricing of its previously announced underwritten public offering of 15,789,475 o...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.12.2025
DYN
LISTED
NASDAQ
Dyne Therapeutics Announces Pricing of Upsized $350.0 Million Public Offering of Common Stock
News Preview
WALTHAM, Mass., Dec. 09, 2025 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage company focused on delivering functional improvement for people living with genetically driven neuromuscular diseases, today announced the pricing of an upsized underwritten public offering of 18,980,478 shares of its common stock at a public...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.12.2025
VERA
LISTED
NASDAQ
Vera Therapeutics Announces Pricing of Public Offering of Class A Common Stock
News Preview
Vera Therapeutics Announces Pricing of Public Offering of Class A Common Stock...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Leerverkaufsstatistiken, Hedge-Fund Aktivitäten und viele weitere nutzerwertige Informationen benutzerfreundlich aufbereitet
© Globe Newswire
10.12.2025
9969
LISTED
HKSE
Over 20 Studies of InnoCare’s Orelabrutinib Presented at the 67th Annual Meeting of the American Society of Hematology (ASH)
News Preview
Orelabrutinib has demonstrated remarkable efficacy and safety in multiple lymphoma studies, including MZL, MCL, CLL/SLL, PCNSL and DLBCL....
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© Globe Newswire
10.12.2025
RWB
LISTED
CSE
Red White & Bloom Brands Closes Debt Settlement
News Preview
TORONTO, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Red White & Bloom Brands Inc. (CSE: RWB) (“RWB” or the “Company”) announces that, further to its news release dated December 1, 2025, it has issued 375,000 common shares at a deemed price of $0.035 per share to a former consultant to settle certain outstanding obligations for past services....
Themefolio
Profiler
Peergroup
© BusinessWire
10.12.2025
RCUS
LISTED
NYSE
Arcus Biosciences Announces New Employment Inducement Grants
News Preview
Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for people with cancer, inflammatory and autoimmune diseases, today announced that the Compensation Committee of the Company’s Board of Directors granted one new employee options to purcha...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.12.2025
BMEA
LISTED
NASDAQ
Biomea Fusion Announces KOL Presentation and Interview on Menin and Icovamenib at WCIRDC 2025
News Preview
SAN CARLOS, Calif., Dec. 09, 2025 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (Nasdaq: BMEA), a clinical stage diabetes and obesity company, today announced the release of a KOL interview during the 23rd World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease (WCIRDC 2025) featuring Dr. Ralph DeFronzo, Professor of Medicine and Ch...
Themefolio
Profiler
Peergroup
© BusinessWire
09.12.2025
GOSS
LISTED
NASDAQ
Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
News Preview
Gossamer Bio, Inc. (Nasdaq: GOSS), a late-stage, clinical biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD), today announced that the Compensation Committee of Gossamer’s B...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.12.2025
IMMX
LISTED
NASDAQ
Immix Biopharma Announces Closing of Upsized $100 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
News Preview
– Financing includes leading U.S. biotechnology institutional investors and mutual funds –...
Themefolio
Profiler
Peergroup
© BusinessWire
09.12.2025
HSTM
LISTED
NASDAQ
HealthStream CEO Rewards Employees with Contribution of Personally Owned Shares of Company Stock
News Preview
HealthStream (Nasdaq: HSTM), a leading healthcare technology platform company for workforce solutions, today announced that its Chief Executive Officer, Robert A. Frist, Jr., has contributed approximately $3.5 million of his personally owned shares of HealthStream common stock for the benefit of HealthStream employees. To accomplish this, Mr. Fris...
Themefolio
Profiler
Peergroup
© BusinessWire
09.12.2025
DNTL
LISTED
TSX
Dentalcorp Obtains Final Court Approval for Acquisition by Investment Funds Affiliated With GTCR
News Preview
dentalcorp Holdings Ltd. (“Dentalcorp” or the “Company”) (TSX: DNTL) announced today that the Company has obtained a final order from the Supreme Court of British Columbia approving the previously-announced plan of arrangement whereby a newly formed acquisition vehicle controlled by GTCR LLC (“GTCR”) will acquire all of Dentalcorp’s issued and out...
Themefolio
Profiler
Peergroup
© PR Newswire
09.12.2025
DHR
LISTED
NYSE
Danaher Announces Quarterly Dividend
News Preview
WASHINGTON, Dec. 9, 2025 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced today that its Board of Directors has approved a regular quarterly cash dividend of $0.32 per share of its common stock, payable on January 30, 2026 to holders of record on December 26, 2025.
ABOUT DANAHERDanaher is a leading global life sciences and diagnostics inn...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© PR Newswire
09.12.2025
BLLN
LISTED
NASDAQ
BillionToOne Appoints Anthony Pagano to Board of Directors as Audit Committee Chair
News Preview
MENLO PARK, Calif., Dec. 9, 2025 /PRNewswire/ – BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, today announced the appointment of Anthony Pagano to its Board of Directors, effective January 1, 2026. Mr. Pagano will also serve as Cha...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.12.2025
ADPT
LISTED
NASDAQ
Adaptive Biotechnologies to Participate in Jefferies Fireside Chat Series on Minimal Residual Disease
News Preview
SEATTLE, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today announced Dr. Harlan Robins, Chief Scientific Officer and Co-Founder and Susan Bobuls...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.12.2025
MDNA
LISTED
TSX
Medicenna Therapeutics to Host a Live Webinar with Q&A to Discuss Updated MDNA11 Clinical Data
News Preview
TORONTO and HOUSTON, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp. (“Medicenna” or the “Company”) (TSX: MDNA, OTCQX: MDNAF), a clinical-stage immunotherapy company focused on the development of Superkines for the treatment of cancer as well as autoimmune and inflammatory diseases is pleased to announce that it will host...
Themefolio
Profiler
Peergroup
© PR Newswire
09.12.2025
AMGN
LISTED
NASDAQ
AMGEN ANNOUNCES 2026 FIRST QUARTER DIVIDEND
News Preview
THOUSAND OAKS, Calif., Dec. 9, 2025 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that its Board of Directors declared a $2.52 per share dividend for the first quarter of 2026. The dividend will be paid on March 6, 2026, to all stockholders of record as of the close of business on February 13, 2026.About Amgen Amgen discovers, develops, ma...
Themefolio
Profiler
Peergroup
© PR Newswire
09.12.2025
NBIX
LISTED
NASDAQ
Neurocrine Biosciences to Host R&D Day on December 16
News Preview
SAN DIEGO, Dec. 9, 2025 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced that it will hold its 2025 R&D Day on Tuesday, December 16, 2025, at 12:00 p.m. Eastern Time (9:00 a.m. Pacific Time) in San Diego....
Themefolio
Profiler
Peergroup
© PR Newswire
09.12.2025
LLY
LISTED
NYSE
Lilly to build $6 billion facility to manufacture active pharmaceutical ingredients in Alabama
News Preview
Huntsville site will focus on domestic production of small molecule synthetic and peptide medicines, including Lilly's oral GLP-1, orforglipronCompany plans to create 3,450 manufacturing and construction jobs at Lilly's ninth U.S. manufacturing site announced since 2020 INDIANAPOLIS, Dec. 9, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) t...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.12.2025
ESPR
LISTED
NASDAQ
Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
News Preview
ANN ARBOR, Mich., Dec. 09, 2025 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that on December 4, 2025, the Company granted three new employees (i) non-qualified stock options to purchase an aggregate of 380,000 shares of common stock, all of which were granted to John Harlow, the Company’s newly appointed Chief Commercial Officer,...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.12.2025
BLLN
LISTED
NASDAQ
BillionToOne Reports Third Quarter 2025 Results
News Preview
MENLO PARK, Calif., Dec. 09, 2025 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, today reported its financial results for the third quarter ended September 30, 2025 and initiated guidance for the remainder of 20...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.12.2025
SGMT
LISTED
NASDAQ
Sagimet Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
News Preview
SAN MATEO, Calif., Dec. 09, 2025 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic and fibrotic pathways, today announced that, in connection with the hiring of three employees, the Compensation Committee of Sagimet’s Board of Dir...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.12.2025
AMRX
LISTED
NASDAQ
Amneal Receives U.S. FDA Approval for Epinephrine Injection in Single- and Multi-Dose Vials for U.S. Hospitals
News Preview
BRIDGEWATER, N.J., Dec. 09, 2025 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (“Amneal” or the “Company”) (Nasdaq: AMRX) today announced that the U.S. Food and Drug Administration (FDA) has approved the Company’s epinephrine injection USP, 1 mg/mL (1 mL), in single-dose vials and 1 mg/mL (30 mL) multi-dose vials. This medicine is a critical t...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.12.2025
DNLI
LISTED
NASDAQ
Denali Therapeutics Announces Proposed Offering of Common Stock and Pre-Funded Warrants
News Preview
SOUTH SAN FRANCISCO, Calif., Dec. 09, 2025 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (NASDAQ: DNLI) today announced that it intends to offer and sell $200 million of shares of its common stock and, in lieu of common stock to certain investors, pre-funded warrants to purchase shares of its common stock in an underwritten public offering. In add...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.12.2025
PRAX
LISTED
NASDAQ
Praxis Precision Medicines Announces Alignment with FDA on Simplified and Accelerated Registrational Pathway for Elsunersen in Early Onset SCN2A Developmental and Epileptic Encephalopathy
News Preview
Clear recognition of high unmet need and urgency for the SCN2A community and plausibility of the mechanism of elsunersen ...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.12.2025
TVGN
LISTED
NASDAQ
Tevogen Celebrates Board Member Dr. Curtis Patton, Honored by Yale University for Distinguished Career and Lasting Contributions to Medical Education and Equity in Medicine
News Preview
Tevogen honors Board Member Dr. Curtis Patton as Yale recognizes his distinguished career, underscoring the Company’s ongoing growth....
Themefolio
Profiler
Peergroup
© Newsfile
09.12.2025
DTR
LISTED
CSE
DiagnosTear Technologies Inc. - Confirmation of No Material Change
News Preview
Vancouver, British Columbia--(Newsfile Corp. - December 9, 2025) - DiagnosTear Technologies Inc. (CSE: DTR) (FSE: X8F) ("DiagnosTear" or the "Company"), a fast-growing innovator in point-of-care ocular diagnostics, at the request of CIRO, wishes to confirm that the Company's management is unaware of any material change in the Company's operations t...
Themefolio
Profiler
Peergroup
© BusinessWire
09.12.2025
STAA
LISTED
NASDAQ
Broadwood Partners Responds to Alcon’s Increase to Proposed Acquisition Price of STAAR Surgical
News Preview
Broadwood Partners, L.P. and its affiliates (collectively, “Broadwood,” “we,” “us” or “our”) today responded to the amended transaction terms of the proposed acquisition of STAAR Surgical Company (“STAAR” or the “Company”) (NASDAQ: STAA) by Alcon Inc. (“Alcon”) (NYSE: ALC).
Broadwood, which owns 30.2% of STAAR’s outstanding common stock, continue...
Themefolio
Profiler
Peergroup
© ACCESS Newswire
09.12.2025
ONCO
LISTED
NEO
Onco-Innovations Chairs Colorectal Cancer Canada Precision Oncology Forum Generating Roadmaps for the Next Era of Cancer Care
News Preview
VANCOUVER, BC / ACCESS Newswire / December 9, 2025 / Onco-Innovations Limited (CBOE CA:ONCO)(Frankfurt:W1H, WKN: A3EKSZ)(OTCQB:ONNVF) ("Onco" or the "Company") is pleased to announce, further to its news release dated September 12, 2025, the completion of the fourth session in Colorectal Cancer Canada's Catalysts: Innovating for...
Themefolio
Profiler
Peergroup
© PR Newswire
09.12.2025
BEAM
LISTED
NASDAQ
Beyond Traditional Drugs: Novel Platforms Targeting Hard-to-Treat Conditions
News Preview
Issued on behalf of Avant Technologies Inc.VANCOUVER, BC, Dec. 9, 2025 /CNW/ -- Equity Insider News Commentary – Traditional pharmaceutical strategies are giving ground as breakthrough approvals for gene therapies and mRNA platforms target previously untreatable rare diseases with precision interventions[1]. Healthcare systems integrating AI diagn...
Themefolio
Profiler
Peergroup
© PR Newswire
09.12.2025
BEAM
LISTED
NASDAQ
Beyond Traditional Drugs: Novel Platforms Targeting Hard-to-Treat Conditions
News Preview
Issued on behalf of Avant Technologies Inc.VANCOUVER, BC, Dec. 9, 2025 /PRNewswire/ -- Equity Insider News Commentary – Traditional pharmaceutical strategies are giving ground as breakthrough approvals for gene therapies and mRNA platforms target previously untreatable rare diseases with precision interventions[1]. Healthcare systems integrating A...
Themefolio
Profiler
Peergroup
© BusinessWire
09.12.2025
ERF
LISTED
EURONEXT
Eurofins Scientific SE: Director/PDMR Shareholding
News Preview
Eurofins Scientific SE (EUFI.PA) has received various notifications of dealing from Persons Discharging Managerial Responsibilities (“PDMR”). The notification of Dealing Form for each PDMR can be found below.
This notification is made in accordance with the European Market Abuse Regulation.
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY...
Themefolio
Profiler
Peergroup
© ACCESS Newswire
09.12.2025
MODD
LISTED
NASDAQ
Modular Medical Announces Proposed Public Offering
News Preview
SAN DIEGO, CA / ACCESS Newswire / December 9, 2025 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical"), an insulin delivery technology company with the first FDA-cleared patch pump designed specifically to target all adult "almost-pumpers" with its user-friendly and affordable design, today announced that it has commenced...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.12.2025
ALSAF
LISTED
EURONEXT
SAFE - RESULTATS SEMESTRIELS 2025
News Preview
RESULTATS SEMESTRIELS 2025...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.12.2025
IPN
LISTED
EURONEXT
IPSEN - Buy-back programme - Art 5 of MAR - Week 49- 2025
News Preview
Attachment...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.12.2025
EL
LISTED
EURONEXT
EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of November 30, 2025
News Preview
Disclosure of Share Capital and Voting Rights Outstanding as of November 30, 2025...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.12.2025
IDIA
LISTED
SIX
Idorsia’s treatment for insomnia disorder wins the inaugural Prix Galien Bridges Award in the ‘Best Biotechnology & Pharmaceutical Product’ category
News Preview
Allschwil, Switzerland – December 9, 2025Idorsia Ltd (SIX: IDIA) announces that its novel treatment for insomnia disorder has been awarded the inaugural Prix Galien Bridges Award in the category of “Best Biotechnology & Pharmaceutical Product”. The award recognizes groundbreaking medicines, including biologics, gene therapies, and traditional p...
Themefolio
Profiler
Peergroup
© PR Newswire
09.12.2025
HURA
LISTED
NASDAQ
TuHURA Biosciences, Inc. Announces $15.6 Million Registered Direct Offering
News Preview
TAMPA, Fla., Dec. 9, 2025 /PRNewswire/ -- TuHURA Biosciences, Inc. (NASDAQ:HURA) ("TuHURA" or the "Company"), a Phase 3 immuno-oncology company developing novel therapeutics to overcome resistance to cancer immunotherapy, today announced that it has entered into a definitive agreement for the purchase of an aggregate of 9,462,423 shares of its com...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.12.2025
ORNBV
LISTED
HEL
Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
News Preview
ORION CORPORATION STOCK EXCHANGE RELEASE / MAJOR SHAREHOLDER ANNOUNCEMENTS9 December 2025 at 17.30 EET ...
Themefolio
Profiler
Peergroup
© PR Newswire
09.12.2025
CODX
LISTED
NASDAQ
Co-Diagnostics to Present on Co-Dx™ PCR Platform and AI Integration at Point-of-Care Testing 2025
News Preview
SALT LAKE CITY, Dec. 9, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced that the Company is delivering a presentation at the Point-of-Care Testing 2025 Exhibition and Conference in...
Themefolio
Profiler
Peergroup
© ActuNews
09.12.2025
BOI
LISTED
EURONEXT
BOIRON : Déclaration des droits de vote au 3O novembre 2025
News Preview
Le 9 décembre 2025
Publication
du nombre d'actions composant le capital et du nombre total de droits de vote
(articles L. 233-8 II du code de commerce et 223-16 du règlement général de l'AMF)
Date d'arrêt des informations
Nombre total d'actions composant le capital
Nombre to...
Themefolio
Profiler
Peergroup
© PR Newswire
09.12.2025
6472
LISTED
TAI
Bora Pharmaceuticals and Corealis Pharma Forge Strategic Alliance to Deliver Seamless, End-to-End Oral Solid Dose Development
News Preview
Partnership creates simplified pathway from early development to commercial launchMAPLE GROVE, Minn., Dec. 9, 2025 /PRNewswire/ -- Bora Pharmaceuticals Co., Ltd. ("Bora", TWSE: 6472), a global leader in pharmaceutical manufacturing, and Corealis Pharma Inc., a leading early-phase Contract Development Manufacturing Organization (CDMO), have entered...
Themefolio
Profiler
Peergroup
© PR Newswire
09.12.2025
CTXR
LISTED
NASDAQ
Citius Oncology Announces $18 Million Concurrent Registered Direct Offering and Private Placement Priced At-The-Market Under Nasdaq Rules
News Preview
Proceeds strengthen cash position and support commercial launch of LYMPHIR™, a novel cancer immunotherapy for cutaneous T-cell lymphoma (CTCL)CRANFORD, N.J., Dec. 9, 2025 /PRNewswire/ -- Citius Oncology, Inc. ("Citius Oncology" or the "Company") (Nasdaq: CTOR), the oncology-focused subsidiary of Citius Pharmaceuticals, Inc. ("Citius Pharma") (Nasd...
Themefolio
Profiler
Peergroup
© BusinessWire
09.12.2025
GILD
LISTED
NASDAQ
Gilead Foundation Awards Over $3 Million to Support People Living With Metastatic Breast Cancer
News Preview
Gilead Foundation today announced a commitment of more than $3 million in new grants to help address critical gaps in education, care delivery and support services for people affected by metastatic breast cancer (mBC). Building on more than $21 million in support since 2021, funding distributed through the Gilead Foundation advances efforts to imp...
Themefolio
Profiler
Peergroup
© BusinessWire
09.12.2025
HCA
LISTED
NYSE
HCA Healthcare Names Virginia Tenpenny Vice President of Community Engagement
News Preview
HCA Healthcare, Inc. (NYSE:HCA), one of the nation’s leading healthcare providers, today announced that Virginia Tenpenny has been named vice president of community engagement, effective January 12, 2026.
In this role, Tenpenny will lead HCA Healthcare’s community engagement strategy, overseeing a team that manages social and charitable investmen...
Themefolio
Profiler
Peergroup
© BusinessWire
09.12.2025
ALC
LISTED
NYSE
Alcon Announces Amended Merger Agreement with STAAR Surgical
News Preview
Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced that it has entered into an amended merger agreement for the acquisition of STAAR Surgical Company (NASDAQ: STAA, “STAAR”), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision corr...
Themefolio
Profiler
Peergroup
© BusinessWire
09.12.2025
TEM
LISTED
NASDAQ
Tempus Announces Ten Abstracts Accepted for Presentation at the 2025 San Antonio Breast Cancer Symposium
News Preview
Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced that ten abstracts have been accepted for presentation at the 2025 San Antonio Breast Cancer Symposium (SABCS). The meeting takes place December 9–12 at the Henry B. González Convention Center in San Antonio, Texas.
“This...
Themefolio
Profiler
Peergroup
© PR Newswire
09.12.2025
ADVM
LISTED
NASDAQ
Lilly and Adverum announce expiration and completion of Adverum tender offer and acquisition
News Preview
INDIANAPOLIS, Dec. 9, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Adverum Biotechnologies, Inc. (NASDAQ: ADVM) today announced that the tender offer (the "Offer") by Flying Tigers Acquisition Corporation ("Purchaser"), a direct wholly-owned subsidiary of Lilly, to purchase all of the issued and outstanding shares ("Shares") of Adve...
Themefolio
Profiler
Peergroup
© PR Newswire
09.12.2025
WWH
LISTED
LSE
Worldwide Healthcare Trust PLC - Net Asset Value(s)
News Preview
WORLDWIDE HEALTHCARE TRUST PLC
LEI: 5493003YBCY4W1IMJU04
NET ASSET VALUE
The estimated un-audited net asset val...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.12.2025
QCLS
LISTED
NASDAQ
Quantum-Class Computing Developer Q/C Technologies Welcomes Strategic Advisor Martin Shkreli
News Preview
New York, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Q/C Technologies, Inc. (Nasdaq: QCLS) (“Q/C” or “the Company”), a pioneer of quantum-class computing at the speed of light, today announced that Martin Shkreli become a Strategic Advisor to the Company, contributing his experience in technology, industry contacts, financial innovation and early-stage gr...
Themefolio
Profiler
Peergroup
© BusinessWire
09.12.2025
GH
LISTED
NASDAQ
Guardant Health and Policlinico Gemelli Launch In-House Liquid Biopsy Testing Service in Italy
News Preview
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the successful launch of FPG 360, an in-house liquid biopsy testing service at the Fondazione Policlinico Universitario Agostino Gemelli IRCCS (Policlinico Gemelli) in Rome, Italy. This partnership is the latest in a series of public-private partnerships Guar...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.12.2025
TFX
LISTED
NYSE
Teleflex Announces Sale of Acute Care, Interventional Urology, and OEM Businesses for $2.03 Billion
News Preview
Board of Directors authorizes new $1 billion share repurchase program Board of Directors authorizes new $1 billion share repurchase program...
Themefolio
Profiler
Peergroup
© PR Newswire
09.12.2025
LUCD
LISTED
NASDAQ
Lucid Diagnostics Announces Positive Data from the Largest Reported Real-World Experience of Esophageal Precancer Detection
News Preview
Report includes nearly 12,000 patients who underwent Lucid's EsoGuard® Esophageal DNA Test on samples collected using its EsoCheck® Esophageal Cell Collection DeviceReal-world data confirm excellent technical performance, very rapid cell-collection times, and appropriate physician use, consistent with previously published studiesNEW YORK, Dec. 9,...
Themefolio
Profiler
Peergroup
© PR Newswire
09.12.2025
ATOS
LISTED
NASDAQ
Atossa Therapeutics Announces Issuance of U.S. Patent Covering Enteric Oral (Z)-Endoxifen Formulations and Methods of Treating Patients Using (Z)-Endoxifen
News Preview
New patent further strengthens global intellectual property estate supporting Atossa's lead program across the breast cancer spectrum and other hormone-driven conditionsSEATTLE, Dec. 9, 2025 /PRNewswire/ -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) ("Atossa" or the "Company"), a clinical-stage biopharmaceutical company developing innovative therapi...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.12.2025
MYGN
LISTED
NASDAQ
Myriad Genetics to Present 8 Abstracts about MRD and Other Studies at 2025 San Antonio Breast Cancer Symposium
News Preview
Myriad Genetics will present new data in eight abstracts at the 2025 San Antonio Breast Cancer Symposium (SABCS)....
Themefolio
Profiler
Peergroup
© Globe Newswire
09.12.2025
HQY
LISTED
NASDAQ
Young Americans Lead in HSA Adoption But Carry Heaviest Economic Burden, HealthEquity Research Finds
News Preview
New Healthcare Affordability Pulse Reveals Generational Divide in Financial Preparedness and Workplace stress New Healthcare Affordability Pulse Reveals Generational Divide in Financial Preparedness and Workplace stress...
Themefolio
Profiler
Peergroup
© BusinessWire
09.12.2025
BNBX
LISTED
NASDAQ
BNB Plus Provides BNB Treasury and Operational Updates
News Preview
BNB Plus Corp. (Nasdaq: BNBX) (“BNBX” or the “Company”), today provided a corporate update highlighting its recent strategic treasury growth, expected significant narrowing of losses at its LineaRx, Inc. (“LineaRx”) subsidiary, and the launch of a new corporate website and branding.
Significant Addition to BNB Treasury
The Company has opportunis...
Themefolio
Profiler
Peergroup
© BusinessWire
09.12.2025
COYA
LISTED
NASDAQ
Coya Therapeutics Announces Patients Have Been Dosed in the ALSTARS Trial of COYA 302 for the Treatment of ALS
News Preview
Coya Therapeutics, Inc. (NASDAQ: COYA) (“Coya” or the “Company”), a clinical-stage biotechnology company focused on developing biologics that enhance regulatory T cell (Treg) function in patients with neurodegenerative disorders, announced that dosing of ALS patients in the Company’s ALSTARS Trial of COYA 302 has commenced.
Dr. Fred Grossman, the...
Themefolio
Profiler
Peergroup
© BusinessWire
09.12.2025
ENVB
LISTED
NASDAQ
Enveric Biosciences Receives Notice of Allowance for EVM301 Series of Drug Candidates
News Preview
Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company advancing novel neuroplastogenic small-molecule therapeutics to address psychiatric and neurological disorders, today announced that it has received a Notice of Allowance from the United States Patent and Trademark Office (“USPTO”) for a patent application per...
Themefolio
Profiler
Peergroup
© BusinessWire
09.12.2025
NTRA
LISTED
NASDAQ
Natera Highlights New Findings in Lymphoma at the ASH Annual Meeting
News Preview
Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today shared the results from two oral presentations that were presented at the American Society of Hematology (ASH) Annual Meeting.
Real-world Signatera Analysis: Oral Presentation on December 6
A real-world analysis of personalized circulating tumor DNA (ctDN...
Themefolio
Profiler
Peergroup
© BusinessWire
09.12.2025
SLP
LISTED
NASDAQ
Simulations Plus Positioned to Capitalize on FDA’s Streamlined Nonclinical Safety Guidance with Advanced Mechanistic and Model-Informed Solutions
News Preview
Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus” or the “Company”), a global leader in model-informed and AI-accelerated drug development that advances biopharma innovation, today responded to the U.S. Food and Drug Administration’s draft guidance on streamlined nonclinical safety studies for monospecific monoclonal antibodies. The guidanc...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
